Skip to content

Clinical trials

Observational beta-Thalassemia trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: beta-Thalassemia Phase: Observational Country / region: Italy Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20161
20181
20201
20211
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia2
Azienda Ospedaliero-Universitaria di Modena1
Cyprus Institute of Neurology and Genetics1
Ente Ospedaliero Ospedali Galliera1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
University of Milano Bicocca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
beta-Thalassemia9
Thalassemia2
Anemia, Sickle Cell1
COVID-191
Endocrine System Diseases1
Hemochromatosis1
Hemoglobinopathies1
Iron Overload1
Myelodysplastic Syndromes1
Pulmonary Arterial Hypertension1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.